A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The transforming genes of oncogenic retroviruses are homologous to a group of evolutionary conserved cellular onc genes. The human cellular homologue (c-abl) of the transforming sequence of Abelson murine leukaemia virus (A-MuL V) was recently shown to be located on chromosome 9. The long arm of this chromosome is involved in a specific translocation with chromosome 22, the Philadelphia translocation (Ph1), t(9; 22) (q34, q11), which occurs in patients with chronic myelocytic leukaemia (CML)3-5. Here we investigate whether the c-abl gene is included in this translocation. Using c-abl and v-abl hybridization probes on blots of somatic cell hybrids, positive hybridization is found when the 22q- (the Philadelphia chromosome), and not the 9q+ derivative of the translocation, is present in the cell hybrids. From this we conclude that in CML, c-abl sequences are translocated from chromosome 9 to chromosome 22q-. This finding is a direct demonstration of a reciprocal exchange between the two chromosomes and suggests a role for the c-abl gene in the generation of CML.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The importance of proto-oncogenes was further highlighted by discoveries that nonviral cancers frequently have genetic alterations in proto-oncogenes that activate them and drive oncogenesis—for example, mutations in H-ras or K-ras (76), gene amplification of c-myc (77), and chromosomal translocation/activation involving c-abl (78).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [78]
Citations
Cites
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
A physical map of the DNA regions flanking the rabbit β-globin gene
Jeffreys, A. (1977) · Cell · doi:10.1016/0092-8674(77)90119-2 · Cited by 644
Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S., & Barbacid, M. (1982) · Nature · doi:10.1038/298343a0 · Cited by 623
Chang, E. H., Furth, M. E., Scolnick, E. M., & Lowy, D. R. (1982) · Nature · doi:10.1038/297479a0 · Cited by 587
Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine
Witte, O. N., Dasgupta, A., & Baltimore, D. (1980) · Nature · doi:10.1038/283826a0 · Cited by 530
Goff, S. P., Gilboa, E., Witte, O. N., & Baltimore, D. (1980) · Cell · doi:10.1016/0092-8674(80)90554-1 · Cited by 470
Khan, P. M. (1971) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(71)80007-3 · Cited by 344
Chromosomal localization of human cellular homologues of two viral oncogenes
Heisterkamp, N., Groffen, J., Stephenson, J. R., Spurr, N. K., Goodfellow, P. N., Solomon, E., Carritt, B., & Bodmer, W. F. (1982) · Nature · doi:10.1038/299747a0 · Cited by 303
Self-citation
Research works printed but not linked: 2
- Heisterkamp, N., Groffen, J. & Stephenson, J. R. J. molec. appl. Genet. (in the press).
- Ferguson-Smith, M. A. & Aitken, D. A. Cytogenet. Cell Genet. 22, 49–451 (1978).
Cited by
Items 101–200 of 1,000
A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia
Cathcart, K., Pinilla-Ibarz, J., Korontsvit, T., Schwartz, J., Zakhaleva, V., Papadopoulos, E. B., & Scheinberg, D. A. (2004) · Blood · doi:10.1182/blood-2003-03-0954 · Cited by 208
Dobson, C. L. (1999) · The EMBO Journal · doi:10.1093/emboj/18.13.3564 · Cited by 207
“A.Forster, I.Lavenir, J.Corral1, A.J.H.Smith2 and T.H.Rabbitts3 MRC Laboratory of Molecular Biology, Division of Protein and Nucleic Acid Chemistry, Hills Road, Cambridge, CB2 2QH, UK 1Present address: Centro Regional de Hemodonacion, Servicio de Hematologia, Hospital Clinico Universitario, Ronda…”
BackgroundAn 8-kilobase abl RNA transcript in chronic myelogenous leukemia.
Gale, R. P., & Canaani, E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.18.5648 · Cited by 208
Bakhshi, A., Minowada, J., Arnold, A., Cossman, J., Jensen, J. P., Whang-Peng, J., Waldmann, T. A., & Korsmeyer, S. J. (1983) · New England Journal of Medicine · doi:10.1056/nejm198310063091404 · Cited by 205
Altered Transcription of the c- abl Oncogene in K-562 and Other Chronic Myelogenous Leukemia Cells
Collins, S. J., Kubonishi, I., Miyoshi, I., & Groudine, M. T. (1984) · Science · doi:10.1126/science.6587568 · Cited by 206
STI571: A Paradigm of New Agents for Cancer Therapeutics
Mauro, M. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.325 · Cited by 202
The mouse c-abl locus: Molecular cloning and characterization
Yin Jen Wang, J., Ledley, F., Goff, S., Lee, R., Groner, Y., & Baltimore, D. (1984) · Cell · doi:10.1016/0092-8674(84)90228-9 · Cited by 208
Grosveld, G., Verwoerd, T., van Agthoven, T., de Klein, A., Ramachandran, K. L., Heisterkamp, N., Stam, K., & Groffen, J. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.2.607 · Cited by 202
Self-citationNegrini, M., Silini, E., Kozak, C., Tsujimoto, Y., & Croce, C. M. (1987) · Cell · doi:10.1016/0092-8674(87)90448-x · Cited by 200
Azim, H. A., Pavlidis, N., & Peccatori, F. A. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.11.004 · Cited by 192
Verfaillie, C., Miller, W., Boylan, K., & McGlave, P. (1992) · Blood · doi:10.1182/blood.v79.4.1003.1003 · Cited by 196
Nucleotide sequence of the human c-myc locus: provocative open reading frame within the first exon.
Gazin, C., Dupont de Dinechin, S., Hampe, A., Masson, J. M., Martin, P., Stehelin, D., & Galibert, F. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb01816.x · Cited by 201
Franz, W. M., Berger, P., & Wang, J. Y. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03358.x · Cited by 202
Wetzler, M., Talpaz, M., Van Etten, R. A., Hirsh-Ginsberg, C., Beran, M., & Kurzrock, R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116786 · Cited by 188
Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia
Soverini, S., Branford, S., Nicolini, F. E., Talpaz, M., Deininger, M. W. N., Martinelli, G., Müller, M. C., Radich, J. P., & Shah, N. P. (2014) · Leukemia Research · doi:10.1016/j.leukres.2013.09.011 · Cited by 185
“Chronic myeloid leukemia (CML) is characterized by the presnce of the Philadelphia chromosome (Ph+), which contains the ncogenic BCR-ABL1 fusion gene resulting from a translocation etween chromosomes 9 and 22 [1,2].”
BackgroundProkocimer, M., & Rotter, V (1994) · Blood · doi:10.1182/blood.v84.8.2391.2391 · Cited by 184
Ross, T. S., Bernard, O. A., Berger, R., & Gilliland, D. G. (1998) · Blood · doi:10.1182/blood.v91.12.4419 · Cited by 186
“Genomic DNA of patient t(5;7)-positive cells (lane 1) and control cells (lane 2) was analyzed by Southern blotting with a 1.”
BackgroundMethodInfluentialThe Cytogenetic Scenario of Chronic Myeloid Leukemia
Mitelman, F. (1993) · Leukemia & Lymphoma · doi:10.3109/10428199309047856 · Cited by 184
Kloetzer, W., Kurzrock, R., Smith, L., Talpaz, M., Spiller, M., Gutterman, J., & Arlinghaus, R. (1985) · Virology · doi:10.1016/0042-6822(85)90361-7 · Cited by 183
Inhibiting TRK Proteins in Clinical Cancer Therapy
Lange, A., & Lo, H.-W. (2018) · Cancers · doi:10.3390/cancers10040105 · Cited by 175
“Recognition of gene fusions as drivers for oncogenesis began with the identification of BCR-Abl as an initiator for chronic myelogenous leukemia in 1982 [31].”
BackgroundDe Klein, A., Hagemeijer, A., Bartram, C., Houwen, R., Hoefsloot, L., Carbonell, F., Chan, L., Barnett, M., Greaves, M., & Kleihauer, E. (1986) · Blood · doi:10.1182/blood.v68.6.1369.1369 · Cited by 179
Self-citationAblation of Fbxw7 Eliminates Leukemia-Initiating Cells by Preventing Quiescence
Takeishi, S., Matsumoto, A., Onoyama, I., Naka, K., Hirao, A., & Nakayama, K. I. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.026 · Cited by 178
“Chronic myeloid leukemia (CML) in humans is characterized by the presence of the Philadelphia chromosome, which is generated by a chromosomal translocation that joins the BCR gene on chromosome 22 to the ABL gene on chromosome 9 (de Klein et al., 1982; Rowley, 1973).”
BackgroundHurtz, C., Hatzi, K., Cerchietti, L., Braig, M., Park, E., Kim, Y.-M., Herzog, S., Ramezani-Rad, P., Jumaa, H., Müller, M. C., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110304 · Cited by 177
Bhatia, R., McGlave, P., Dewald, G., Blazar, B., & Verfaillie, C. (1995) · Blood · doi:10.1182/blood.v85.12.3636.bloodjournal85123636 · Cited by 178
Human RhoGAP domain‐containing proteins: structure, function and evolutionary relationships
Peck, J., Douglas, G., Wu, C. H., & Burbelo, P. D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03331-8 · Cited by 176
Micronuclei in exfoliated human cells as a tool for studies in cancer risk and cancer intervention
Stich, H. F., & Rosin, M. P. (1984) · Cancer Letters · doi:10.1016/0304-3835(84)90159-9 · Cited by 172
Ribeiro, R., Abromowitch, M., Raimondi, S., Murphy, S., Behm, F., & Williams, D. (1987) · Blood · doi:10.1182/blood.v70.4.948.948 · Cited by 173
ONCOGENE ACTIVATION BY CHROMOSOME TRANSLOCATION IN HUMAN MALIGNANCY
Haluska, F. G., Tsujimoto, Y., & Croce, C. M. (1987) · Annual Review of Genetics · doi:10.1146/annurev.ge.21.120187.001541 · Cited by 171
Chromosomal localisation of the human homologues to the oncogenes erbA and B.
Spurr, N. K., Solomon, E., Jansson, M., Sheer, D., Goodfellow, P. N., Bodmer, W. F., & Vennstrom, B. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb01777.x · Cited by 167
Self-citationLi, X., He, Y., Ruiz, C. H., Koenig, M., & Cameron, M. D. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.025932 · Cited by 163
Chu, S., Holtz, M., Gupta, M., & Bhatia, R. (2004) · Blood · doi:10.1182/blood-2003-04-1271 · Cited by 163
Chronic myelogenous leukemia: A review
Cortes, J. E., Talpaz, M., & Kantarjian, H. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00061-7 · Cited by 163
BONE MARROW TRANSPLANTATION: A REVIEW OF DELAYED COMPLICATIONS
Deeg, H. J., Storb, R. F., & Thomas, E. D. (1984) · British Journal of Haematology · doi:10.1111/j.1365-2141.1984.tb02887.x · Cited by 159
Oncogenes in Myeloproliferative Disorders
Tefferi, A., & Gilliland, D. G. (2007) · Cell Cycle · doi:10.4161/cc.6.5.3919 · Cited by 162
Is the chromosomal region 9q34 always involved in variants of the Ph1 translocation?
Hagemeijer, A., Bartram, C. R., Smit, E. M. E., van Agthoven, A. J., & Bootsma, D. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90083-9 · Cited by 158
Self-citationWarfvinge, R., Geironson, L., Sommarin, M. N. E., Lang, S., Karlsson, C., Roschupkina, T., Stenke, L., Stentoft, J., Olsson-Strömberg, U., Hjorth-Hansen, H., et al. (2017) · Blood · doi:10.1182/blood-2016-07-728873 · Cited by 154
Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Bernt, K. M., & Hunger, S. P. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00054 · Cited by 169
“The BCR–ABL1 fusion gene is generated by joining almost the entire coding region of the ABL1 tyrosine kinase gene (Abelson murine leukemia virus homolog, exons 2–11, chromosome 9) to the breakpoint cluster region (BCR) gene on chromosome 22 (Figure 2) (21).”
BackgroundTotal Synthesis of the Antitumor Depsipeptide FR-901,228
Li, K. W., Wu, J. J., Xing, W., & Simon, J. A. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9613724 · Cited by 167
ALTERED TRANSCRIPTION OF AN ONCOGENE IN CHRONIC MYELOID LEUKAEMIA
Canaani, E., Steiner-Salz, D., Aghai, E., Gale, R. P., Berrebi, A., & Januszewicz, E. H. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90997-8 · Cited by 153
Mayerhofer, M., Florian, S., Krauth, M., Aichberger, K. J., Bilban, M., Marculescu, R., Printz, D., Fritsch, G., Wagner, O. F., Selzer, E., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1200 · Cited by 154
“This translocation fuses the c-abl gene from chromosome 9 to the bcr gene locus on chromosome 22 (3).”
Chromosomal sublocalization of human c-myb and c-fes cellular onc genes
Harper, M., Franchini, G., Love, J., Simon, M. I., Gallo, R. C., & Wong‐Staal, F. (1983) · Nature · doi:10.1038/304169a0 · Cited by 151
Kelman, Z., Prokocimer, M., PELLER, S., Kahn, Y., Rechavi, G., Manor, Y. S., Cohen, A., & Rotter, V. (1989) · Blood · doi:10.1182/blood.v74.7.2318.2318 · Cited by 151
the Viral and Cellular Forms of the Abelson (Dbl) Oncogene
Rosenberg, N. E., & Witte, O. N. (1988) · Advances in virus research · doi:10.1016/s0065-3527(08)60708-3 · Cited by 150
How does DNA break during chromosomal translocations?
Nambiar, M., & Raghavan, S. C. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr223 · Cited by 166
“A well-studied example is the recurrent t(11;22)(q23;q11) chromosomal translocation which harbors palindromic AT-rich repeat (PATRR) sequences on both the breakpoint regions (131).”
BackgroundInfluentialBarnett, M. J., Eaves, C. J., Phillips, G. L., Gascoyne, R. D., Hogge, D. E., Horsman, D., Humphries, R. K., Hg, K., Lansdorp, P., & Nantel, S. H. (1994) · Blood · doi:10.1182/blood.v84.3.724.724 · Cited by 146
White, D. L., Saunders, V. A., Lyons, A. B., Branford, S., Grigg, A., To, L. B., & Hughes, T. P. (2005) · Blood · doi:10.1182/blood-2005-03-1103 · Cited by 155
Yang‐Feng, T. L., Francke, U., & Ullrich, A. (1985) · Science · doi:10.1126/science.3873110 · Cited by 155
Armstrong, C., Schubert, J. E. A., Ueda, E., Knez, J. J., Gelperin, D. M., Hirose, S., Silber, R., Hollán, S. R., Schmidt, R. E., & Medof, M. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74046-0 · Cited by 144
Diagnosis and Treatment of Chronic Myeloid Leukemia in 2015
Thompson, P. A., Kantarjian, H. M., & Cortes, J. E. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.08.010 · Cited by 172
Bhatia, R., Wayner, E. A., McGlave, P. B., & Verfaillie, C. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117333 · Cited by 145
Associations between morphology, karyotype, and clinical features in myeloid leukemias
Bitter, M. A., Beau, M. M. L., Rowley, J. D., Larson, R. A., Golomb, H. M., & Vardiman, J. W. (1987) · Human Pathology · doi:10.1016/s0046-8177(87)80002-3 · Cited by 143
Immunological off-target effects of imatinib
Zitvogel, L., Rusakiewicz, S., Routy, B., Ayyoub, M., & Kroemer, G. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.41 · Cited by 142
Genomic disorders 20 years on—mechanisms for clinical manifestations
Harel, T., & Lupski, J. R. (2017) · Clinical Genetics · doi:10.1111/cge.13146 · Cited by 162
“This has been well documented for the red-green opsin genes in color blindness,(89,90) as well as for specific proto-oncogenes in cancer syndromes, where fusion genes are potentially druggable.(91,92) Moreover, complex rearrangements with inversions can result in novel fusion transcripts that evolve novel genes.”
BackgroundC‐abl and bcr are rearranged in a Ph1‐negative CML patient.
Bartram, C. R., Kleihauer, E., de Klein, A., Grosveld, G. C., Teyssier, J., Heisterkamp, N., & Groffen, J. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03683.x · Cited by 142
Self-citationPierson, B., & Miller, J. (1996) · Blood · doi:10.1182/blood.v88.6.2279.bloodjournal8862279 · Cited by 141
“Even though clonogenic frequency of the CD56+br'gh' and CD56+di" NK remain unchanged from normal values in ECP CML, four significant therapy-independent defects can be observed in NK from patients with ECP CML compared with normal donors: (1) the absolute number of circulating NK is reduced, (2) the absolute number of…”
ResultGenomic diversity correlates with clinical variation in Ph′-negative chronic myeloid leukaemia
Morris, C. M., Reeve, A. E., Fitzgerald, P. H., Hollings, P. E., Beard, M., & Heaton, D. C. (1986) · Nature · doi:10.1038/320281a0 · Cited by 141
Zhou, H., Du, M., & Dixit, V. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.012 · Cited by 145
“Introduction in CML places the Abelson (ABL) tyrosine kinase gene under the regulation of the promoter for the breakpoint cluster regionTumor development and progression are frequently associated (BCR) gene (de Klein et al., 1982).”
BackgroundRe-emergence of interferon-α in the treatment of chronic myeloid leukemia
Talpaz, M., Hehlmann, R., Quintás-Cardama, A., Mercer, J., & Cortes, J. (2013) · Leukemia · doi:10.1038/leu.2012.313 · Cited by 137
Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32)
Keersmaecker, K. D., Graux, C., Odero, M. D., Mentens, N., Somers, R., Maertens, J. A., Włodarska, I., Vandenberghe, P., Hagemeijer, A., Marynen, P., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4897 · Cited by 139
Self-citationExisting and Emerging Technologies for Tumor Genomic Profiling
MacConaill, L. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.5948 · Cited by 150
“(1) When using a hybrid-capture approach, mission-critical exons may sometimes be missed (due to challenges with GC%, content, and uneven capture efficiency).”
MethodThompson, F. H., Emerson, J., Olson, S., Weinstein, R. S., Leavitt, S. A., Leong, S. P. L., Emerson, S. S., Trent, J. M., Nelson, M. A., Salmon, S. E., et al. (1995) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(95)00057-v · Cited by 138
myc oncogenes: activation and amplification
Alitalo, K. K., Koskinen, P. J., Mäkelä, T. P., Saksela, K., Sistonen, L., & Winqvist, R. (1987) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(87)90016-3 · Cited by 149
Reynolds, T. C., Smith, S. D., & Sklar, J. (1987) · Cell · doi:10.1016/0092-8674(87)90667-2 · Cited by 137
O’Connell, C. M., O’Brien, S. J., Nash, W. G., & Cohen, M. (1984) · Virology · doi:10.1016/0042-6822(84)90347-7 · Cited by 137
Levy-Strumpf, N., & Kimchi, A. (1998) · Oncogene · doi:10.1038/sj.onc.1202588 · Cited by 136
Cytogenetic studies on patients with chronic T cell leukemia/lymphoma
Ueshima, Y., Rowley, J., Variakojis, D., Winter, J. N., & Gordon, L. I. (1984) · Blood · doi:10.1182/blood.v63.5.1028.1028 · Cited by 136
The BCR gene and philadelphia chromosome-positive leukemogenesis.
Laurent, E., Talpaz, M., Kantarjian, H. M., & Kurzrock, R. (2001) · PubMed · Cited by 176
Patterns of the early, gross chromosomal changes in malignant human gliomas
Bigner, S. H., Mark, J., Mahaley, M. S., & Bigner, D. D. (2008) · Hereditas · doi:10.1111/j.1601-5223.1984.tb00455.x · Cited by 134
Specific inhibition of cytoplasmic protein tyrosine kinases by herbimycin A in vitro
Fukazawa, H., Pei-Mlng, L., Yamamoto, C., Murakami, Y., Mizuno, S., & Yoshimasa, U. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90500-5 · Cited by 133
Comparative map for mice and humans
Nadeau, J. H., Davisson, M. T., Doolittle, D. P., Grant, P., Hillyard, A. L., Kosowsky, M., & Roderick, T. H. (1992) · Mammalian Genome · doi:10.1007/bf00778825 · Cited by 137
Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics
Tefferi, A., Skoda, R. C., & Vardiman, J. W. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.149 · Cited by 151
Adolescent and young adult patients with cancer: a milieu of unique features
Sender, L., & Zabokrtsky, K. B. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.92 · Cited by 130
Gadd45 Stress Sensors in Malignancy and Leukemia
Liebermann, D. A., Tront, J. S., Sha, X., Mukherjee, K., Mohamed-Hadley, A. A., & Hoffman‐Liebermann, B. (2011) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v16.i1-2.120 · Cited by 144
Chronic myeloid leukemia: reminiscences and dreams
Mughal, T. I., Radich, J. P., Deininger, M. W., Apperley, J. F., Hughes, T. P., Harrison, C. J., Gambacorti-Passerini, C. B., Saglio, G. N., Cortes, J. E., & Daley, G. Q. (2016) · Haematologica · doi:10.3324/haematol.2015.139337 · Cited by 145
BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations
Pane, F., Intrieri, M., Quintarelli, C., Izzo, B., Casadei, G. M., & Salvatore, F. (2002) · Oncogene · doi:10.1038/sj.onc.1206094 · Cited by 145
“…9, were shown to hybridize on chromosome 22q- (the Ph chromosome) of somatic cell hybrids originating from human CML leukocytes and rodent cells (de Klein et al., 1982), while sequences of the c-sis oncogene, generally found on chromosome 22, were shown to be translocated to the chromosome 9 in…”
BackgroundMolecular Cloning and Characterization of p56 Defines a New Family of RasGAP-binding Proteins
Di Cristofano, A., Carpino, N., Dunant, N., Friedland, G., Kobayashi, R., Strife, A., Wisniewski, D., Clarkson, B., Pandolfi, P. P., & Resh, M. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.4827 · Cited by 129
Clinical Implications of Tumor-Cell Heterogeneity
Epstein, F. H., & Schnipper, L. E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605293142206 · Cited by 136
Sawyers, C. L., Timson, L. K., Kawasaki, E. S., Clark, S., Witte, O. N., & Champlin, R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.563 · Cited by 128
Chronic Myeloproliferative Disorders in Bone Marrow Biopsies
Georgii, A., Vykoupil, K. F., Buhr, T., Choritz, H., Döhler, U., Kaloutsi, V. D., & Werner, M. (1990) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)81008-3 · Cited by 127
Dan, S., Naito, M., & Tsuruo, T. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400400 · Cited by 126
Zhang, Y., Gostissa, M., Hildebrand, D. G., Becker, M. S., Boboila, C., Chiarle, R., Lewis, S., & Alt, F. W. (2010) · Advances in Immunology · doi:10.1016/s0065-2776(10)06004-9 · Cited by 123
“The BCR–ABL fusion protein retained the tyrosine kinase activity of the parent ABL gene andwas shown to be oncogenic (Bartram et al., 1983; de Klein et al., 1982; Groffen et al., 1984; Heisterkamp et al., 1983).”
Genomic and proteomic biomarkers for cancer: A multitude of opportunities
Tainsky, M. A. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.04.004 · Cited by 150
Secondary Mutation Maintains the Transformed State in BaF3 Cells With Inducible BCR/ABL Expression
Klucher, K. M., Lopez, D. V., & Daley, G. Q. (1998) · Blood · doi:10.1182/blood.v91.10.3927 · Cited by 123
Cytogenetic analysis of 39 pediatric central nervous system tumors
Karnes, P. S., Tran, T. N., Cui, M. Y., Raffel, C., Gilles, F. H., Barranger, J. A., & Ying, K. L. (1992) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(92)90150-7 · Cited by 122
Targeting cell cycle regulators in hematologic malignancies
Aleem, E., & Arceci, R. J. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00016 · Cited by 120
“Patients with chronic myeloid leukemia (CML) carry the BCR/ABL fusion protein (De Klein et al., 1982; Shtivelman et al., 1985).”
BackgroundNam, C.-H., & Rabbitts, T. H. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.010 · Cited by 122
Bhatia, R., McCarthy, J., & Verfaillie, C. (1996) · Blood · doi:10.1182/blood.v87.9.3883.bloodjournal8793883 · Cited by 123
Comprehensive, integrated, and phased whole-genome analysis of the primary ENCODE cell line K562
Zhou, B., Ho, S. S., Greer, S. U., Zhu, X., Bell, J. M., Arthur, J. G., Spies, N., Zhang, X., Byeon, S., Pattni, R., et al. (2019) · Genome Research · doi:10.1101/gr.234948.118 · Cited by 123
“The hallmark of CML is the Philadelphia rearrangement t(9; 22)(q34; q11) which results in the fusion of the ABL1 and BCR genes (Heisterkamp et al. 1985; de Klein et al. 1982; Groffen et al. 1984).”
Wang, Q., Xia, J., Jia, P., Pao, W. J., & Zhao, Z. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbs044 · Cited by 126
Tefferi, A., & Gilliland, D. G. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.7.947 · Cited by 126
Andersen, M. H., Bonfill, J. E., Neisig, A., Arsequell, G., Søndergaard, I., Neefjes, J., Zeuthen, J., Elliott, T., & Haurum, J. S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3812 · Cited by 117
Xiphophorus As An In Vivo Model for Studies on Normal and Defective Control of Oncogenes
Anders, F., Schartl, M., Barnekow, A., & Anders, A. (1984) · Advances in cancer research · doi:10.1016/s0065-230x(08)60459-5 · Cited by 117
Giacomini, C. P., Sun, S., Varma, S., Shain, A. H., Giacomini, M. M., Balagtas, J. M. S., Sweeney, R. T., Lai, E., Fitz, C. D. V., Forster, A. D., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003464 · Cited by 123
DNA double-strand break repair and chromosome translocations
Agarwal, S., Tafel, A. A., & Kanaar, R. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.05.029 · Cited by 134
Lionberger, J. M., Wilson, M. B., & Smithgall, T. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000126200 · Cited by 115
Eaves, C. J., Cashman, J., Wolpe, S. D., & Eaves, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12015 · Cited by 115
Neural regulation of bone and bone marrow
Maryanovich, M., Takeishi, S., & Frenette, P. S. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031344 · Cited by 114
“For instance, a mouse model of chronic myelogenous leukemia (CML), which is caused by a chromosomal translocation that joins the BCR and ABL genes (Rowley 1973; de Klein et al. 1982), was established by generation of inducible BCR-ABL transgenic mice (Reynaud et al. 2011).”
BackgroundChronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies
Clarkson, B., Strife, A., Wisniewski, D. J., Lambek, C. L., & Liu, C. (2003) · Leukemia · doi:10.1038/sj.leu.2402912 · Cited by 133
Fragile sites and predisposition to leukemia and lymphoma
Yunis, J. J. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90011-6 · Cited by 113
Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia.
Keersmaecker, K. D., Marynen, P., & Cools, J. (2005) · Lirias · Cited by 136
Metadata
- Authors
- Klein, A. D., Kessel, A. G. V., Grosveld, G., Bartram, C. R., Hagemeijer, A., Bootsma, D., Spurr, N. K., Heisterkamp, N., Groffen, J., & Stephenson, J. R.
- Affiliations
- Erasmus University Rotterdam (NL)
- National Cancer Institute (US)
- Venue
- Nature
- Published
- 1982-12
- Volume
- 300
- Issue
- 5894
- Pages
- 765-767
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2060833726
- Cited by
- 1,378
- References
- 27
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 17 · 2023: 12 · 2022: 25 · 2021: 17 · 2020: 18 · 2019: 15 · 2018: 23 · 2017: 28 · 2016: 24 · 2015: 33 · 2014: 16 · 2013: 26 · 2012: 33
- FWCI
- 50.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- Philadelphia chromosome, chromosome 9, chromosome 22, reciprocal translocation, cellular oncogenes, somatic cell hybrids
- MeSH terms
- Chromosomes, Human, 21-22 and Y, Chromosomes, Human, 6-12 and X, DNA, Neoplasm, Gene Expression Regulation, Humans, Leukemia, Myeloid, Oncogenes, Translocation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.